MedPath

Comparing the effectiveness of melatonin with placebo in reducing the level of interleukin-6 in operated infants.

Phase 3
Conditions
Severity of inflammation in operated babies.
Registration Number
IRCT20200109046061N2
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

Age limit below one month
Hospitalized for surgery
Consent of the family to participate in the plan

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of melatonin on reducing the level of interleukin 6. Timepoint: Day before surgery. Day three after surgery. Method of measurement: Kate Eliza.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath